1. Home
  2. IKT vs ONEW Comparison

IKT vs ONEW Comparison

Compare IKT & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$2.41

Market Cap

220.5M

Sector

Health Care

ML Signal

HOLD

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$11.21

Market Cap

211.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IKT
ONEW
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto & Home Supply Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
220.5M
211.7M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
IKT
ONEW
Price
$2.41
$11.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$5.00
$16.50
AVG Volume (30 Days)
373.8K
104.5K
Earning Date
03-26-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
57.76
N/A
EPS
N/A
2.77
Revenue
N/A
$1,872,334,000.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
$3.14
P/E Ratio
N/A
$4.22
Revenue Growth
N/A
5.62
52 Week Low
$1.33
$8.12
52 Week High
$2.61
$17.35

Technical Indicators

Market Signals
Indicator
IKT
ONEW
Relative Strength Index (RSI) 50.59 40.73
Support Level $2.29 $10.19
Resistance Level $2.53 $12.11
Average True Range (ATR) 0.11 0.70
MACD -0.01 -0.03
Stochastic Oscillator 36.76 2.13

Price Performance

Historical Comparison
IKT
ONEW

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

Share on Social Networks: